Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menggang Yu

Showing results (41-50 of 176) with videos related to

Pageof 18
Sort By:
Statistics in Medicine|October 3, 2014
Bayesian approach for flexible modeling of semicompeting risks dataBaoguang Han, Menggang Yu, James J Dignam, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 29, 2026
A quantitative framework to assess the potential of earlier cancer detection to improve cancer survivalMenggang Yu, Christopher Tyson, Paul J Limburg, et al.
Statistics in Medicine|June 28, 2016
Identification of subgroups with differential treatment effects for longitudinal and multiresponse variablesWei-Yin Loh, Haoda Fu, Michael Man, et al.
Pharmacoepidemiology and Drug Safety|October 17, 2012
A new "Comparative Effectiveness" assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazoneRichard Tannen, Dawei Xie, Xingmei Wang, et al.
Biometrics|September 9, 2014
Meta-analysis based variable selection for gene expression dataQuefeng Li, Sijian Wang, Chiang-Ching Huang, et al.
Statistical Methods in Medical Research|August 3, 2013
Advanced colorectal neoplasia risk stratification by penalized logistic regressionYunzhi Lin, Menggang Yu, Sijian Wang, et al.
Haematologica|February 9, 2012
Genetic disruption of the PI3K regulatory subunits, p85α, p55α, and p50α, normalizes mutant PTPN11-induced hypersensitivity to GM-CSFCharles B Goodwin, Zhenyun Yang, Fuqin Yin, et al.
BMC Medical Research Methodology|January 31, 2022
Which test for crossing survival curves? A user's guidelineIna Dormuth, Tiantian Liu, Jin Xu, et al.
Statistics in Medicine|November 7, 2025
Regional Consistency Evaluation and Sample Size Calculation Under Two MRCTsKunhai Qing, Xinru Ren, Shuping Jiang, et al.
Plos One|April 25, 2013
Stat3 downstream gene product chitinase 3-like 1 is a potential biomarker of inflammation-induced lung cancer in multiple mouse lung tumor models and humansCong Yan, Xinchun Ding, Lingyan Wu, et al.
Pageof 18

Showing results (41-50 of 176) with videos related to

Sort By:
Pageof 18
Statistics in Medicine|October 3, 2014
Bayesian approach for flexible modeling of semicompeting risks dataBaoguang Han, Menggang Yu, James J Dignam, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 29, 2026
A quantitative framework to assess the potential of earlier cancer detection to improve cancer survivalMenggang Yu, Christopher Tyson, Paul J Limburg, et al.
Statistics in Medicine|June 28, 2016
Identification of subgroups with differential treatment effects for longitudinal and multiresponse variablesWei-Yin Loh, Haoda Fu, Michael Man, et al.
Pharmacoepidemiology and Drug Safety|October 17, 2012
A new "Comparative Effectiveness" assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazoneRichard Tannen, Dawei Xie, Xingmei Wang, et al.
Biometrics|September 9, 2014
Meta-analysis based variable selection for gene expression dataQuefeng Li, Sijian Wang, Chiang-Ching Huang, et al.
Statistical Methods in Medical Research|August 3, 2013
Advanced colorectal neoplasia risk stratification by penalized logistic regressionYunzhi Lin, Menggang Yu, Sijian Wang, et al.
Haematologica|February 9, 2012
Genetic disruption of the PI3K regulatory subunits, p85α, p55α, and p50α, normalizes mutant PTPN11-induced hypersensitivity to GM-CSFCharles B Goodwin, Zhenyun Yang, Fuqin Yin, et al.
BMC Medical Research Methodology|January 31, 2022
Which test for crossing survival curves? A user's guidelineIna Dormuth, Tiantian Liu, Jin Xu, et al.
Statistics in Medicine|November 7, 2025
Regional Consistency Evaluation and Sample Size Calculation Under Two MRCTsKunhai Qing, Xinru Ren, Shuping Jiang, et al.
Plos One|April 25, 2013
Stat3 downstream gene product chitinase 3-like 1 is a potential biomarker of inflammation-induced lung cancer in multiple mouse lung tumor models and humansCong Yan, Xinchun Ding, Lingyan Wu, et al.
Pageof 18